Paclitaxel similarly resulted in an increased the level of γ-H2AX that could be attenuated by UCN-01 or MitoQ (Supplementary Fig. 6A and B) and rescued the impaired proliferation of paclitaxel-treated cancer cells (Supplementary Fig. 6C and D). Here, H2AX is linked to cancer.